MercyIn the care of the sick, great tenderness above all things. - Catherine McAuley, Founder, Sisters of Mercy

Physician Referal 1.800.MD-Mercy  Mercy Sponsored by the Sisters of Mercy 301 St. Paul Place Baltimore, MD 21202 Phone: 410.332.9000 TTY: 410.332.9888 web: www.MDMercy.com Privacy Policy

Media Relations: Medical Experts Profiles:
Kathy J. Helzlsouer, M.D., M.H.S.

Kathy J. Helzlsouer, M.D., M.H.S.

FIELD: Cancer Research, Women’s Preventive Health, Epidemiology

POSITION/TITLE: Director, The Prevention and Research Center at Mercy Medical Center

BACKGROUND: Dr. Helzlsouer, an oncologist and epidemiologist, joined Mercy in October 2004 to spearhead Mercy’s efforts in clinical research and to expand clinical programs in cancer risk assessment and cancer survivorship. She is Adjunct Professor of Epidemiology for the Hopkins University Bloomberg School of Public Health where she previously served as head of the cancer epidemiology program. Dr. Helzlsouer has numerous research publications and presentations to her credit. She is widely recognized for particular expertise in clinical epidemiology, cancer epidemiology and cancer prevention.

The Prevention and Research Center spearheads efforts to improve the health and well being of patients through clinical research. Research activities focus on cancer survivorship, women’s health and improving birth outcomes, and cancer treatment trials. Clinical services offered in the center include the cancer risk assessment and genetic counseling, the Cancer Recovery Program which provides programs and consultation services for cancer survivors, including the Be Well Stay Healthy Program, the Be Well Stay Healthy KIDS! Program, a support program for children whose parents have had cancer, and support programs for individuals at high risk of developing cancer.

For more information on research studies and clinical services call 410 951 7950. The Prevention and Research Center is housed in two locations. Its clinical services are located on the 6th floor of the Weinberg Center; research staff are located on the third floor of Mercy’s Shamrock Building.

Dr. Helzlsouer currently serves as the Chair, Cancer Control Council for the state of Maryland, Interim Chair of the Maryland Cancer Registry Advisory Committee, Chair, Molecular Epidemiology Group of the American Association for Cancer Research, member of the PDQ Cancer Screening and Prevention Committee of the National Cancer Institute (NCI), and as member of an Institute of Medicine Committee on Environment and Breast Cancer.

MISCELLANEOUS: In November 2007, DCEG (The Division of Cancer Epidemiology and Genetics) and The Division of Cancer Control and Population Sciences (DCCPS) hosted the annual meeting of the NCI (National Cancer Institute) Cohort Consortium in Bethesda, Outgoing secretariat member Dr. Kathy J. Helzlsouer, Director of Prevention & Research at Mercy Medical Center in Baltimore, MD, received an NCI Award for Outstanding Service in Recognition of Leadership and Scientific Vision.

In July 2008, Dr. Helzlsouer was designated Chair of the Council on Cancer Control by Maryland Governor Martin O’Malley. As Chair, Dr. Helzlsouer oversees the activities of The Maryland State Council on Cancer Control, a 25-member body appointed by the Governor. Members are selected from State agencies and administrations involved in cancer screening, prevention and treatment services, as well as from the general public, the business community, health and scientific disciplines concerned with cancer control. The Council advises the Governor, other government officials, public and private organizations and the general public on comprehensive State policies and programs necessary to reduce and control the incidence and mortality of cancer in Maryland.

In December 2009, Dr. Helzlsouer was named Chair of the Molecular Epidemiology Group (MEG) of the American Association for Cancer Research (AACR). MEG is a scientific working group of epidemiologists, molecular biologists and geneticists, biochemists, toxicologists, nutritionists, clinical and translational researchers, pathologists, biostatisticians, ethicists and researchers from any other relevant scientific discipline who are interested in working together to increase knowledge about cancer and chronic disease etiology, thereby promoting the cure and prevention of cancer and the improvement of public health.